Revolution Medicines, Inc.
DE ˙ DB ˙ US76155X1000
135,15 € ↑1,10 (0,82%)
2026-06-03
AKTIENPREIS
SecurityDE:42Z / Revolution Medicines, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership13,682 shares
Latest Disclosed Value $ 1,330,575
Prudential Financial Inc reports 65.70% increase in ownership of 42Z / Revolution Medicines, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 13,682 shares of Revolution Medicines, Inc. (DE:42Z) valued at $1,121,924 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 8,257 shares of Revolution Medicines, Inc.. This represents a change in shares of 65.70% during the quarter. The current value of the position is $1,849,122 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 13,682 5,425 65.70 1,331 102.44 0.0009
2026-02-13 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 8,257 -4,882 -37.16 658 7.18 0.0008
2025-11-13 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 13,139 -34,465 -72.40 614 -64.99 0.0007
2025-08-12 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 47,604 1,495 3.24 1,751 7.42 0.0023
2025-05-13 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 46,109 -750 -1.60 1,630 -20.45 0.0023
2025-02-11 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 46,859 4,645 11.00 2,050 7.05 0.0028
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 42,214 4,855 13.00 1,914 32.09 0.0027
2024-08-13 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 37,359 22,400 149.74 1,450 200.62 0.0022
2024-05-14 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 14,959 4,625 44.76 482 62.84 0.0007
2024-02-13 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 10,334 10,334 296 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.